Search Results

There are 14302 results for: content related to: The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

  1. Current prospects for interferon-free treatment of hepatitis C in 2012

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 38–45, Catherine AM Stedman

    Article first published online : 19 DEC 2012, DOI: 10.1111/jgh.12028

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 88–102, Tarik Asselah and Patrick Marcellin

    Article first published online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02699.x

  4. You have free access to this content
    New therapeutic strategies in HCV: polymerase inhibitors

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 85–92, Ludmila Gerber, Tania M. Welzel and Stefan Zeuzem

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12068

  5. You have free access to this content
    New HCV therapies on the horizon

    Clinical Microbiology and Infection

    Volume 17, Issue 2, February 2011, Pages: 122–134, J. Vermehren and C. Sarrazin

    Article first published online : 20 JAN 2011, DOI: 10.1111/j.1469-0691.2010.03430.x

  6. You have free access to this content
    The end of the beginning for hepatitis C treatment

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 664–665, Douglas Dieterich

    Article first published online : 23 FEB 2012, DOI: 10.1002/hep.25528

  7. Novel Therapeutic Approaches for Hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 78–88, JS Au and PJ Pockros

    Article first published online : 19 DEC 2013, DOI: 10.1038/clpt.2013.206

  8. You have free access to this content
    New horizons in hepatitis C antiviral therapy with direct-acting antivirals

    Hepatology

    Volume 58, Issue 1, July 2013, Pages: 428–438, Alessio Aghemo and Raffaele De Francesco

    Article first published online : 31 MAY 2013, DOI: 10.1002/hep.26371

  9. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  10. Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed

    Hepatology

    Volume 62, Issue 1, July 2015, Pages: 129–134, Stanislas Pol, Mark S. Sulkowski, Tarek Hassanein, Edward J. Gane, Lin Liu, Hongmei Mo, Brian Doehle, Bittoo Kanwar, Diana Brainard, G. Mani Subramanian, William T. Symonds, John G. McHutchison, Ronald G. Nahass, Michael Bennett and Ira M. Jacobson

    Article first published online : 20 MAY 2015, DOI: 10.1002/hep.27836

  11. You have free access to this content
    Abstracts 1–199

    Hepatology

    Volume 52, Issue S1, October 2010, Pages: 320A–421A,

    Article first published online : 30 SEP 2010, DOI: 10.1002/hep.23974

  12. New Pharmacotherapy for Hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 3, September 2012, Pages: 294–305, D N Assis and J K Lim

    Article first published online : 1 AUG 2012, DOI: 10.1038/clpt.2012.103

  13. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  14. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Article first published online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  15. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27516

  16. You have free access to this content
    Optimal therapy in genotype 4 chronic hepatitis C: finally cured?

    Liver International

    Volume 35, Issue s1, January 2015, Pages: 27–34, Wael Abdel-Razek and Imam Waked

    Article first published online : 22 DEC 2014, DOI: 10.1111/liv.12724

  17. Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients

    Hepatology Research

    Volume 41, Issue 12, December 2011, Pages: 1153–1168, Yasuteru Kondo, Yoshiyuki Ueno, Yuta Wakui, Masashi Ninomiya, Eiji Kakazu, Jun Inoue, Koju Kobayashi, Noriyuki Obara and Tooru Shimosegawa

    Article first published online : 26 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00878.x

  18. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Article first published online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  19. You have free access to this content
    Current and emerging antiviral treatments for hepatitis C infection

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 931–943, Joseph S. Doyle, Esther Aspinall, Danny Liew, Alexander J. Thompson and Margaret E. Hellard

    Article first published online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04419.x

  20. You have free access to this content
    Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 54–60, Mitchell L. Shiffman and Rafael Esteban

    Article first published online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02718.x